This inventor holds 1 USPTO granted patent. Top assignee: Egis Gyogyszergyar Rt.. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Marta Szanto: Innovator in Pharmaceutical Compositions
Introduction
Marta Szanto is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly with her innovative work on gemfibrozil-containing compositions. Her dedication to improving pharmaceutical formulations has led to the development of a unique oral solid composition that enhances the efficacy of the active ingredient.
Latest Patents
Marta Szanto holds a patent for her invention titled "Gemfibrozil containing pharmaceutical compositions." This invention relates to an oral solid pharmaceutical composition that includes gemfibrozil as the active ingredient. The composition also contains conventional pharmaceutical auxiliary agents, specifically a surfactant known as bis-(2-ethyl-hexyl)-sodium-sulfosuccinate, in an amount of 0.05-0.5% by weight relative to the gemfibrozil content. The innovative aspect of her formulation is that it utilizes a relatively small amount of surfactant, which ensures uniform dissolution of the active ingredient across different batches, resulting in a low standard deviation of the dissolution rate.
Career Highlights
Marta Szanto is associated with Egis Gyogyszergyar Rt., a prominent pharmaceutical company in Hungary. Her work at Egis has allowed her to focus on research and development in the pharmaceutical sector, where she has made impactful contributions to drug formulation and delivery systems.
Collaborations
Marta has collaborated with several talented individuals in her field, including Andrea Sandorfalvy and Denes Bezzegh. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas, ultimately leading to advancements in pharmaceutical technology.
Conclusion
Marta Szanto's contributions to the pharmaceutical industry, particularly through her patent on gemfibrozil compositions, highlight her role as an innovator in the field. Her work not only enhances the effectiveness of medications but also demonstrates the importance of collaboration in driving advancements in pharmaceutical science.